Treatment in South Korea
Advanced technology, fast diagnostics, and treatment for complex conditions at costs up to 70% lower than in Western countries.
Benefits of Treatment in South Korea
01
Costs 30–70% Lower
The same procedure in the United States or Japan often costs significantly more. South Korean hospitals combine advanced medicine with competitive pricing.
02
Fast Diagnosis
Most health screening programmes take only 3–6 hours. Doctors usually issue a final report, including AI-assisted image analysis, within 2–7 days.
03
Advanced Medical Technology
Leading hospitals routinely use da Vinci robotic systems, proton therapy, CyberKnife, and 3D endoscopic surgery for greater precision and improved recovery.
04
Internationally Trained Specialists
Many physicians have completed fellowships in the US, Europe, or Japan. Multilingual coordinators support patients from the initial enquiry through discharge.
Medical Specialties in South Korea
South Korea specialises in high-tech medicine and complex clinical cases. International patients most often seek oncology, neurosurgery, orthopaedics, cardiac surgery, diagnostics, fertility treatment, and rehabilitation services. Treatment follows strict clinical protocols and relies on advanced medical technology available at major university and private hospitals.
Medical tourism in South Korea remains strongly driven by aesthetic medicine, which accounts for 38.5% of the country’s medical tourism market. The current trend focuses on natural-looking results through SMAS facelifts, 3D jaw contouring, rhinoplasty, and regenerative anti-ageing treatments. Prices are typically 30–50% lower than in the US or Singapore.
South Korean cancer centres report some of the world’s strongest survival outcomes. Five-year survival for lung cancer reaches 63.6%, compared with 28.1% reported in the United States. Hospitals use PET-CT, 3T MRI, da Vinci robotic surgery, proton therapy, CyberKnife, targeted therapy, and immunotherapy. Every complex case undergoes review by a multidisciplinary Tumor Board. Samsung Comprehensive Cancer Center ranks No. 3 globally in Newsweek’s 2026 cancer hospital ranking.
Mortality rates for open-heart surgery average approximately 2.3%, compared with a global benchmark of 5.8%. South Korean cardiac surgeons routinely perform coronary artery bypass grafting (CABG), valve replacement, TAVI/TAVR procedures, coronary stenting, and radiofrequency ablation. Advanced 3D modelling and intraoperative navigation help reduce surgical risk. Most patients remain in hospital for 14–21 days following major cardiac procedures.
Leading centres perform knee and hip replacement surgery with robotic-assisted systems that improve implant alignment and long-term durability. For spine surgery, many hospitals use 3D biportal endoscopic techniques, which help minimise tissue trauma and reduce the risk of nerve injury. Common indications include herniated discs, spinal stenosis, scoliosis, and spinal deformities.
South Korea is recognised as a global leader in living donor liver transplantation (LDLT). Hospitals perform ABO-incompatible transplants and complex dual-graft procedures. Ten-year survival after liver transplantation consistently exceeds 85%. South Korea also performed the country’s first robotic lung transplantation.
Leading fertility centres, including CHA Hospital, MizMedi, and Miraeyeon, report IVF success rates of approximately 60–65%. Treatment protocols include personalised ovarian stimulation, ICSI, preimplantation genetic testing (PGD/PGS), and blastocyst-stage embryo culture.
These results place South Korea among the leading IVF destinations worldwide.
Dental tourism in South Korea grew by 588% in 2025. Clinics use intraoral scanners, CAD/CAM milling systems, and 3D surgical guides to deliver highly accurate treatment. Many centres provide zirconia crowns in a single visit through Same-Day Crown technology. Dental implants and orthodontic treatment typically cost 30–50% less than in the US and Western Europe.
Cost of Treatment in South Korea
South Korea combines advanced healthcare infrastructure with competitive pricing. As a result, many procedures cost 30–70% less than in the United States, Japan, and Western Europe.
Final costs depend on the hospital, diagnosis, treatment plan, and length of stay.
Check-Up & Diagnostics
$800 - 3 500
Breast Cancer Surgery
$10 000 - 15 000
Robotic Prostatectomy
$14 000
Gamma Knife Radiosurgery
$14 000 - 16 000
Chemotherapy (per cycle)
$2 000 - 5 000
PET-CT Scan
$1 200 - 2 500
Coronary Artery Bypass Surgery
$22 500
Heart Valve Replacement
$19 000 - 23 000
Joint Replacement Surgery
$16 000 - 23 000
Microsurgical Hernia Repair
$13 500 - 21 000
Full IVF Program
$4 500 - 7 000
SMAS Facelift
$9 500 - 20 000
Breast Augmentation
$5 000 - 7 000
Leading Hospitals in South Korea
Samsung Medical Center
A pioneer in healthcare digitalisation and home to one of the world’s leading cancer centres. The hospital offers proton therapy, AI-assisted navigation, and advanced robotic surgery.
Asan Medical Center
The largest hospital in South Korea. Recognised internationally for oncology, gastroenterology, cardiology, and several other specialties.
Severance Hospital
The country’s leading hospital for international patient volume for eight consecutive years. Surgeons have performed more than 20,000 robotic procedures.
Patient Pathway for Treatment in South Korea
01
Submit Your Medical Request
02
Receive a Consultation and Treatment Plan
03
Travel and Accommodation Arrangements
04
Treatment in South Korea
05
Recovery and Follow-Up Care
Frequently Asked Questions
Get a Personalised Treatment Plan
Contact Us
Message us anytime. Our coordinators respond within 1 hour.
Online Now
or
Email: info@saulyk.com
Phone: +90 506 801 03 77
Why Patients Choose Treatment in South Korea
Treatment in South Korea attracts more than 1.17 million international patients every year from 202 countries. Patients travel here for robotic cancer surgery, organ transplantation, advanced cardiac care, and detailed diagnostics at leading university hospitals with multilingual support.
Compared with the United States and Western Europe, treatment costs are typically 30–70% lower while clinical outcomes remain comparable or, in many specialties, exceed international benchmarks.